vs

Side-by-side financial comparison of FIRST COMMONWEALTH FINANCIAL CORP (FCF) and HARROW, INC. (HROW). Click either name above to swap in a different company.

FIRST COMMONWEALTH FINANCIAL CORP is the larger business by last-quarter revenue ($133.7M vs $89.1M, roughly 1.5× HARROW, INC.). FIRST COMMONWEALTH FINANCIAL CORP runs the higher net margin — 28.1% vs 7.4%, a 20.6% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 13.0%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 5.5%).

First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

FCF vs HROW — Head-to-Head

Bigger by revenue
FCF
FCF
1.5× larger
FCF
$133.7M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+20.4% gap
HROW
33.3%
13.0%
FCF
Higher net margin
FCF
FCF
20.6% more per $
FCF
28.1%
7.4%
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
5.5%
FCF

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FCF
FCF
HROW
HROW
Revenue
$133.7M
$89.1M
Net Profit
$37.5M
$6.6M
Gross Margin
79.3%
Operating Margin
17.5%
Net Margin
28.1%
7.4%
Revenue YoY
13.0%
33.3%
Net Profit YoY
14.8%
-2.2%
EPS (diluted)
$0.37
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCF
FCF
HROW
HROW
Q1 26
$133.7M
Q4 25
$137.9M
$89.1M
Q3 25
$136.0M
$71.6M
Q2 25
$131.0M
$63.7M
Q1 25
$118.0M
$47.8M
Q4 24
$120.4M
$66.8M
Q3 24
$121.2M
$49.3M
Q2 24
$120.2M
$48.9M
Net Profit
FCF
FCF
HROW
HROW
Q1 26
$37.5M
Q4 25
$44.9M
$6.6M
Q3 25
$41.3M
$1.0M
Q2 25
$33.4M
$5.0M
Q1 25
$32.7M
$-17.8M
Q4 24
$35.8M
$6.8M
Q3 24
$32.1M
$-4.2M
Q2 24
$37.1M
$-6.5M
Gross Margin
FCF
FCF
HROW
HROW
Q1 26
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Operating Margin
FCF
FCF
HROW
HROW
Q1 26
Q4 25
40.9%
17.5%
Q3 25
38.1%
20.6%
Q2 25
32.1%
17.9%
Q1 25
34.8%
-23.5%
Q4 24
37.1%
19.3%
Q3 24
33.4%
2.7%
Q2 24
38.7%
3.1%
Net Margin
FCF
FCF
HROW
HROW
Q1 26
28.1%
Q4 25
32.5%
7.4%
Q3 25
30.4%
1.4%
Q2 25
25.5%
7.8%
Q1 25
27.7%
-37.2%
Q4 24
29.8%
10.1%
Q3 24
26.5%
-8.6%
Q2 24
30.9%
-13.2%
EPS (diluted)
FCF
FCF
HROW
HROW
Q1 26
$0.37
Q4 25
$0.44
$0.20
Q3 25
$0.39
$0.03
Q2 25
$0.32
$0.13
Q1 25
$0.32
$-0.50
Q4 24
$0.35
$0.19
Q3 24
$0.31
$-0.12
Q2 24
$0.36
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCF
FCF
HROW
HROW
Cash + ST InvestmentsLiquidity on hand
$72.9M
Total DebtLower is stronger
$154.9M
$250.0M
Stockholders' EquityBook value
$1.6B
$52.4M
Total Assets
$12.3B
$399.5M
Debt / EquityLower = less leverage
0.10×
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCF
FCF
HROW
HROW
Q1 26
Q4 25
$72.9M
Q3 25
$74.3M
Q2 25
$53.0M
Q1 25
$66.7M
Q4 24
$47.2M
Q3 24
$72.6M
Q2 24
$71.0M
Total Debt
FCF
FCF
HROW
HROW
Q1 26
$154.9M
Q4 25
$261.7M
$250.0M
Q3 25
$262.1M
$347.2M
Q2 25
$262.4M
$250.6M
Q1 25
$262.7M
$256.9M
Q4 24
$263.0M
$262.7M
Q3 24
$136.3M
$230.7M
Q2 24
$136.6M
$236.3M
Stockholders' Equity
FCF
FCF
HROW
HROW
Q1 26
$1.6B
Q4 25
$1.6B
$52.4M
Q3 25
$1.5B
$47.0M
Q2 25
$1.5B
$49.7M
Q1 25
$1.4B
$56.5M
Q4 24
$1.4B
$69.7M
Q3 24
$1.4B
$58.0M
Q2 24
$1.4B
$58.5M
Total Assets
FCF
FCF
HROW
HROW
Q1 26
$12.3B
Q4 25
$12.3B
$399.5M
Q3 25
$12.3B
$363.1M
Q2 25
$12.2B
$345.0M
Q1 25
$11.8B
$364.2M
Q4 24
$11.6B
$389.0M
Q3 24
$12.0B
$351.5M
Q2 24
$11.6B
$306.6M
Debt / Equity
FCF
FCF
HROW
HROW
Q1 26
0.10×
Q4 25
0.17×
4.77×
Q3 25
0.17×
7.39×
Q2 25
0.17×
5.05×
Q1 25
0.18×
4.55×
Q4 24
0.19×
3.77×
Q3 24
0.10×
3.98×
Q2 24
0.10×
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCF
FCF
HROW
HROW
Operating Cash FlowLast quarter
$8.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
9.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCF
FCF
HROW
HROW
Q1 26
Q4 25
$187.5M
$8.4M
Q3 25
$49.5M
$16.6M
Q2 25
$30.4M
$-803.0K
Q1 25
$55.9M
$19.7M
Q4 24
$129.5M
$-17.8M
Q3 24
$53.6M
$3.0M
Q2 24
$22.7M
$-2.7M
Free Cash Flow
FCF
FCF
HROW
HROW
Q1 26
Q4 25
$171.5M
$8.1M
Q3 25
$16.4M
Q2 25
$-969.0K
Q1 25
$19.5M
Q4 24
$113.9M
$-18.3M
Q3 24
$2.3M
Q2 24
$-3.1M
FCF Margin
FCF
FCF
HROW
HROW
Q1 26
Q4 25
124.3%
9.1%
Q3 25
22.9%
Q2 25
-1.5%
Q1 25
40.8%
Q4 24
94.6%
-27.4%
Q3 24
4.8%
Q2 24
-6.3%
Capex Intensity
FCF
FCF
HROW
HROW
Q1 26
Q4 25
11.7%
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.4%
Q4 24
12.9%
0.8%
Q3 24
1.2%
Q2 24
0.7%
Cash Conversion
FCF
FCF
HROW
HROW
Q1 26
Q4 25
4.18×
1.27×
Q3 25
1.20×
16.26×
Q2 25
0.91×
-0.16×
Q1 25
1.71×
Q4 24
3.61×
-2.62×
Q3 24
1.67×
Q2 24
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons